Effects of Vitamin D Supplementation on C-peptide and 25-hydroxyvitamin D Concentrations at 3 and 6 Months
Scott, Jamil B.
Bennett, Gary G.
Hollis, Bruce W.
Emmons, Karen M.
Drake, Bettina F.Note: Order does not necessarily reflect citation order of authors.
MetadataShow full item record
CitationChandler, P. D., E. L. Giovannucci, J. B. Scott, G. G. Bennett, K. Ng, A. T. Chan, B. W. Hollis, et al. 2015. “Effects of Vitamin D Supplementation on C-peptide and 25-hydroxyvitamin D Concentrations at 3 and 6 Months.” Scientific Reports 5 (1): 10411. doi:10.1038/srep10411. http://dx.doi.org/10.1038/srep10411.
AbstractThe link between African-Americans’ disproportionate rates of diabetes, obesity and vitamin D deficiency may be marked by C-peptide as an indicator of insulin secretion. We hypothesize that vitamin D supplementation will increase C-peptide, a marker of insulin secretion. During 3 winters from 2007-2010, 328 healthy African-Americans (median age, 51 years) living in Boston, MA were randomized into a 4-arm, double-blind trial for 3 months of placebo, 1000, 2000, or 4000 IU of vitamin D3. The differences in non-fasting C-peptide between baseline and 3 months were −0.44 ng/mL for those receiving placebo, −0.10 ng/mL for those receiving 1000 IU/d, 0 ng/mL for those receiving 2000 IU/d, 1.24 ng/mL for those receiving 4000 IU/d (C-peptide increased 0.42 ng/mL for each additional 1000 IU/d of vitamin D3, p < 0.001). Vitamin D supplementation increased C-peptide in overweight African-Americans and may be compatible with other recommendations for diabetes prevention and management including weight loss and increased physical activity.
Citable link to this pagehttp://nrs.harvard.edu/urn-3:HUL.InstRepos:17295542